NewAmsterdam Pharma Company N.V.

NasdaqGM:NAMS Stock Report

Market Cap: US$2.3b

NewAmsterdam Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:NAMS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Sep 24BuyUS$17,333Juliette AudetIndividual1,104US$15.70
20 Aug 24BuyUS$81,350Michael DavidsonIndividual5,000US$16.27
20 Jun 24BuyUS$86,309Michael DavidsonIndividual5,000US$17.26
26 Mar 24BuyUS$181,224Frazier Life Sciences Management, LPCompany8,429US$21.50
13 Feb 24BuyUS$95,000Louis LangeIndividual5,000US$19.00

Insider Trading Volume

Insider Buying: NAMS insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NAMS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,103,4261.19%
Private Companies2,500,7072.71%
Hedge Funds8,024,5658.69%
General Public10,798,26111.7%
Institutions27,362,59629.6%
VC/PE Firms42,596,31746.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.2%.

Top Shareholders

Top 25 shareholders own 82.88% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.2%
Frazier Life Sciences Management, LP
12,226,943US$305.3m0%11.52%
12.8%
Forbion Capital Partners B.V.
11,831,461US$295.4m0%44.21%
11.3%
Bain Capital Life Sciences Investors, LLC
10,473,913US$261.5m0%23.48%
8.73%
RA Capital Management, L.P.
8,064,000US$201.4m2.54%2.15%
8.69%
Viking Global Investors LP
8,024,565US$200.4m0%0.68%
4.4%
The Morningside Group Limited
4,060,923US$101.4m0%20.47%
3.11%
Medicxi Ventures (UK) LLP
2,869,565US$71.7m0%13.83%
2.7%
Forbion International Management B.V.
2,498,438US$62.4m0%no data
2.49%
Cormorant Asset Management, LP
2,300,000US$57.4m53.3%2.47%
1.66%
Adage Capital Management, L.P.
1,530,000US$38.2m-16.1%0.06%
1.65%
BVF Partners L.P.
1,521,948US$38.0m0%0.91%
1.26%
Millennium Management LLC
1,165,429US$29.1m23%0.02%
1.1%
Jennison Associates LLC
1,020,278US$25.5m8.87%0.01%
1.1%
Janus Henderson Group plc
1,019,957US$25.5m60.3%0.01%
1.1%
Pictet Asset Management Limited
1,016,847US$25.4m48.7%0.02%
1.09%
Polar Capital Holdings Plc
1,002,586US$25.0m-20%0.09%
0.97%
GMT Capital Corp.
891,836US$22.3m-5.44%0.66%
0.94%
Deerfield Management Company, L.P. Series C
869,250US$21.7m30.3%0.34%
0.89%
Michael Davidson
818,563US$20.4m0.61%no data
0.87%
Artal Group S.A.
800,000US$20.0m0%0.41%
0.73%
Medical Strategy GmbH, Asset Management Arm
671,177US$16.8m5,790%0.95%
0.61%
Avidity Partners Management, L.P.
559,300US$14.0m17.8%0.55%
0.52%
Woodline Partners LP
483,388US$12.1m0%0.11%
0.46%
BioGeneration Ventures B.V.
427,831US$10.7m0%100.0%
0.46%
Affinity Asset Advisors, LLC
423,155US$10.6m47.9%1.6%